From the 100-day cough to the 100-year life: pertussis, prevention and the future of life course immunisation

24 Apr, 2026

From the 100-day cough to the 100-year life

Europe saw a sharp resurgence of Pertussis in 2024, with cases more than tripling across the region. In England, infections rose by 1,600%, exceeding levels seen during the 2012 outbreak. Nearly 60% of confirmed cases are now in people aged 15 and over – a clear sign that this is no longer just a childhood disease.

As populations live longer, the risks associated with infectious diseases like pertussis grow – both for individuals and for health systems. Undetected infections in adults can drive wider transmission, including to infants who face the greatest risk of severe illness.

We interviewed 28 experts from across Europe and Australia to understand how to respond. Their insights point to a consistent set of barriers – and practical actions that governments can take now.

Key barriers and solutions

  • Poor diagnosis
    Symptoms in older people are often missed or misdiagnosed, allowing outbreaks to spread and affecting quality of life.
    Action:
    • Strengthen real-time surveillance systems, with better national, regional and local reporting.
  • Uneven healthcare professional awareness and low prioritisation
    Limited awareness and understanding of adult vaccination reduces detection, treatment and vaccine uptake.
    Actions:
    • Improve training and guidance for healthcare professionals, particularly those working with at-risk groups
    • Integrate pertussis into multi-pathogen PCR testing for respiratory infections to reduce costs and increase coverage
  • Poor awareness among the adult population
    The belief that pertussis is only a childhood disease continues to limit adult vaccination uptake.
    Action:
    • Introduce call and recall systems, supported by clear public information on risks and benefits of vaccination across the life course.
  • Lack of national recommendations
    Guidance on adult vaccination varies significantly across countries, with some lacking clear recommendations altogether.
    Actions:
    • Establish clear national targets for adult pertussis vaccination, including boosters
    • Work towards a shared European ambition to increase adult vaccination coverage

The resurgence of pertussis is a warning sign. Infectious diseases do not respect age boundaries, and health systems designed around childhood vaccination alone are no longer sufficient. Strengthening life-course immunisation, improving detection and closing awareness gaps should be treated as a health security priority – central to supporting longer, healthier lives.

To view the report, click the button below.